This site is intended for our International customers. If you wish to visit our US site, please choose your appropriate region using the selector in the top right of this page.

Icon / Search Created with Sketch.
Icon / Close Created with Sketch.

MosaiQ™ Benefits

The distinct benefits of MosaiQ™

MosaiQ was specifically designed to address the challenges of today’s resource-constrained transfusion diagnostics environment. Here are a few of the many benefits you can expect with MosaiQ. 

Improved clinical decision-making:

By facilitating better matching of donor and patient blood, MosaiQ-screened blood products can potentially reduce the incidence of alloimmunization and other adverse reactions.

Consolidation of multiple analyzers:

The consolidation and standardization of immunohematology and disease screening analyzers translates to numerous advantages for your lab:

  • Reduced need for training on multiple systems for lab staff.
  • The prospect of fewer contracts and vendors to manage.

Streamlined inventory management:

  • With a targeted microarray shelf life of 6 months, there is potential for more efficient inventory management and consequently less frequent batch acceptance of red cell reagents.
  • RFID tracking of all reagents and microarray magazines allows for improved safety and simplified tracking/management of Microarrays and reagents.

Advanced testing capabilities:

  • When fully loaded, MosaiQ can test up to 1000 microarrays.
  • With MosaiQ, the first result is delivered in under 35 minutes with subsequent results every 24 seconds afterwards including:
    • Blood grouping
    • Extended phenotyping
    • Antibody detection
    • Exclusion of other clinically significant antibodies
    • Donor disease screening
  • MosaiQ needs less than 2 ml of whole blood to undertake both comprehensive blood grouping and serological disease screening.